Who
Soria Ester Banque
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Moderna; Executive Vice President, Zoetis.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 31 Jul 2023
- Last trade
- 5 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jul 2026filed 7 Jul 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,658 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,364 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,658 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,364 at $0.00 | filing |
| 4 Oct 2024filed 8 Oct 2024 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $9,423154.3 at $61.07 | filing |
| 31 Jul 2024filed 1 Aug 2024 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —895.02 | filing |
| 31 Jul 2024filed 1 Aug 2024 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —895 | filing |
| 31 Jul 2024filed 1 Aug 2024 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $55K307 at $180.04 | filing |
| 12 Jul 2024filed 15 Jul 2024 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,077140.4 at $57.53 | filing |
| 5 Apr 2024filed 9 Apr 2024 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,34625.25 at $53.31 | filing |
| 6 Feb 2024filed 8 Feb 2024 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,433 at $0.00 | filing |
| 6 Feb 2024filed 8 Feb 2024 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,514 at $0.00 | filing |
| 31 Jul 2023filed 2 Aug 2023 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,658 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.